Skip to main content
Download PDF

CMTM3 protects the gastric epithelial cells from apoptosis and promotes IL-8 by stabilizing NEMO during Helicobacter pylori infection

Gut Pathogens volume 15, Article number: 6 (2023) Cite this article

Abstract

Background

CKLF-like MARVEL transmembrane domain containing 3 (CMTM3) plays an important role in cancer development. Although Helicobacter pylori (H. pylori) infection is a main cause of gastric cancer, the function of CMTM3 during H. pylori infection remains unclear. CMTM3 expression levels in tissues from H. pylori-infected patients and cells co-cultured with H. pylori were analyzed. qRT-PCR and ELISA were used to investigate the effects of CMTM3 on interleukin 8 (IL-8) expression. Annexin V/propidium iodide staining was performed to evaluate the function of CMTM3 in the apoptosis of gastric epithelial cells. Proteomic analysis was performed to explore the underlying mechanism of CMTM3 during H. pylori infection. The interaction between CMTM3 and NEMO was determined via co-immunoprecipitation, HA-ubiquitin pull-down assay, and immunofluorescence.

Results

H. pylori induced a significant increase in CMTM3 expression. CMTM3 inhibited gastric mucosal epithelial cells from apoptosis and increased the expression level of IL-8 during H. pylori infection. KEGG pathway enrichment analysis revealed that differentially expressed proteins were involved in epithelial cell signaling in H. pylori infection. CMTM3 directly interacted with NEMO, which promoted protein stabilization by down-regulation of its ubiquitylation.

Conclusions

CMTM3 reduces apoptosis and promotes IL-8 expression in the gastric epithelial cells by stabilizing NEMO during H. pylori infection. These findings characterize a new role for CMTM3 in host–pathogen interactions and provide novel insight into the molecular regulation of NEMO.

Background

Over half of the human population is infected with Helicobacter pylori (H. pylori), a major cause of gastritis, peptic ulcer disease, and gastric cancer [1]. Eradication of H. pylori reduces gastric cancer incidence [2]; however, as drug-resistant strains of H. pylori are increasing, the eradication rate under triple antibiotic therapy is less than 80% in most countries around the world [3]. The proportion of H. pylori annual recurrence is 13% in developing countries [4]. These problems perplex clinicians throughout the world. The immune response plays an effective role in reducing bacterial load; therefore, understanding the host immune response to H. pylori is essential for eliminating the pathogen. As the first cell type to interact with H. pylori and the main source of the interleukin 8 (IL-8) after H. pylori infection, gastric epithelial cells play a critical role in the H. pylori-associated immune response [5]. H. pylori induces apoptosis in gastric epithelial cells via death receptors in the plasma membrane, which leads to the cleavage of procaspase-8 and release of cytochrome from mitochondria, and activation of subsequent apoptotic events [6].

The nuclear factor κB (NF-κB) pathway, which has a central role in the innate immune response against viral and bacterial infections, increases the expression of IL-8, and promotes cell survival [7, 8]. H. pylori with cag pathogenicity island encoding type 4 secretion system, induces the NF-κB pathway [9]. After H. pylori infection, IκBα kinase (IKK)—composed of the catalytic subunits IKKα and IKKβ and the scaffold IKKγ/NEMO—activates and phosphorylates IκBα, resulting in IκBα degradation [10,11,12]. Thereafter, NF-κB dimers translocate to the nucleus and target downstream DNA sequences involved in the inhibition of viruses and bacteria, induction of cytokine and anti-apoptosis proteins expression [13, 14].

CKLF-like MARVEL transmembrane domain containing 3 (CMTM3) belongs to the CMTM family [15, 16]. The CMTM3 gene is a novel gastric cancer suppressor gene that restrains cell migration and invasion [17,18,19,20,21]. However, it’s also reported that CMTM3 has a pro-tumorigenic effect in pancreatic cancer, glioblastoma, and hepatocellular carcinoma. Although the link between H. pylori infection and gastric cancer is established, the role of CMTM3 during H. pylori infection is unknown.

In this study, we used CMTM3 knockout and overexpress cells to demonstrate the physiological role of CMTM3 and showed that CMTM3 is a positive regulator of the NF-κB pathway upon H. pylori infection. CMTM3 interacts specifically with NEMO and mediates ubiquitylation and degradation of NEMO in response to infection. These findings suggest that interaction between CMTM3 and NEMO is essential for maintenance of homeostasis in the immune system.

Results

Up-regulation of CMTM3 expression after H. pylori infection

The expression of CMTM3 in the gastric mucosal samples collected before and after H. pylori infection from the same patient was determined using immunohistochemistry (Fig. 1a). CMTM3 expression was up-regulated in the H. pylori-infected gastritis sample compared to the uninfected ones (Fig. 1b). C57BL/6 mice were challenged with Brucella broth (negative control, NC) or with the PMSS1 strain for 8 weeks (Fig. 1c). H. pylori immunohistochemistry staining (Fig. 1d) and 16S rRNA quantitative real-time polymerase chain reaction (qRT-PCR) (Fig. 1e) were used to detect H. pylori colonization. EPCAM is a marker of gastric mucosa epithelial cells. We isolated EPCAM-positive cells and analyzed the proportion of CMTM3-positive cells in single cell suspensions from mice gastric tissues using flow cytometry (Fig. 1f). The expression level of CMTM3 H. pylori-positive mice was higher than uninfected mice (Fig. 1g).

Fig. 1
figure 1

CMTM3 expression increases during H. pylori infection. a CMTM3 expression level in the gastric mucosa from the same patient before and after H. pylori infection (n = 11) were investigated by immunohistochemistry of CMTM3. b Graph showing the average quantification of CMTM3-positive cells in at least 6 random fields of one patient. Data are expressed as means ± SEM. c Establishment of the C57BL/6 mouse model of H. pylori infection. d&e H. pylori colonization was identified by H. pylori immunohistochemical staining (d) and 16S rRNA qRT-PCR (e). f, g The gating strategy for the percentage of CMTM3-positive cells in mice gastric tissue (f). EPCAM is a maker of gastric mucosa epithelial. Total cells (1 × 106) were counted for analysis. The percentage of CMTM3-positive cells in the Brucella broth (negative control, NC) and PMSS1 groups was compared (g). h–k CMTM3 expressions in GES-1 and AGS cells, treated with H. pylori, were detected by qRT-PCR (h, i) and western blotting (j, k). β-Actin was used as a loading control. Data is representative of three independent experiments and presented as the mean ± SEM. l Luciferase assay of GES-1 transfected with control (pGL3-Basic) or pGL3-Basic-CMTM3-promotor plasmid. Renilla vector was used as an internal control plasmid. The relative luciferase activity was calculated as Firefly/Renilla ratio. Data is representative of three independent experiments and presented as the mean ± SEM. *p < 0.05, **p < 0.01

Full size image

The change of CMTM3 was verified by H. pylori-cell co-culture experiments, in vitro. CagA + VacA + H. pylori strain 26,695 infection increased the expression of CMTM3 in GES-1 and AGS cells (Fig. 1h–k). A dual-luciferase activity assay of GES-1cells, transiently transfected with pGL3-Basic-CMTM3-promotor, revealed that H. pylori infection induced an increase in CMTM3 at the transcriptional level (Fig. 1l).

CMTM3 promotes IL-8 production and inhibits apoptosis of gastric epithelial cells during H. pylori infection

Some CMTM family members are immunity regulators [22,23,24]. H. pylori induces IL-8 expression in gastric epithelial cells, which is an important source of IL-8 [25]. Therefore, we explored the function of CMTM3 on IL-8. Firstly, we measured the CMTM3 expression level in GES-1 and AGS cells. GES-1 is a immortalized gastric epithelial cell line and AGS is a gastric adenocarcinoma cell line. CMTM3 expression was higher in GES-1 compared to AGS cells (Fig. 2a). Therefore, we knocked out CMTM3 in GES-1 cells (Fig. 2b) and overexpressed CMTM3 in AGS cells (Fig. 2c). We treated CMTM3 knockout (CMTM3 KO) GES-1 cells with H. pylori for 24 h and measured IL-8 levels with qRT-PCR and enzyme-linked immunosorbent assay (ELISA). We found that the expression levels of IL-8 were lower in CMTM3 KO GES-1 cells than in control cells (LentiV2) (Fig. 2d, e). IL-8 levels were elevated in CMTM3-overexpressing (pCMV-CMTM3) AGS cells 24 h post-infection, compared to the control cells (pCMV) (Fig. 2f, g). These data indicate that CMTM3 acts as a positive regulator of IL-8 during H. pylori infection.

Fig. 2
figure 2

CMTM3 promotes IL-8 expression and inhibits the apoptosis of gastric epithelial cells. a CMTM3 expression in GES-1 and AGS cells were analyzed by western blotting. b The knockout efficiency of CMTM3 was analyzed by western blotting in GES-1 cells. c The overexpression efficiency of CMTM3 was analyzed by western blotting in AGS cells. d, e CMTM3 knockout (CMTM3 KO) and control (LentiV2) GES-1 cells were treated with H. pylori infection for 24 h. Levels of IL-8 were evaluated by qRT-PCR (d) and ELISA (e). f, g CMTM3 overexpression (pCMV-CMTM3) and control (pCMV) AGS cells were treated with H. pylori for 24 h. Levels of IL-8 were evaluated by qRT-PCR (f) and ELISA (g). h, i Representative Annexin V/propidium iodide staining of CMTM3 KO and control (LentiV2) GES-1 cells treated with H. pylori for 24 h (h) and the proportions of Annexin V-positive cells (i). *p < 0.05, **p < 0.01, ***p < 0.001

Full size image

H. pylori induces apoptosis of healthy gastric epithelial cells [26]. Annexin V/propidium iodide assay was used to detect apoptosis induced by H. pylori in CMTM3 KO GES-1 cells. CMTM3 inhibited H. pylori-induced apoptosis 24 h post-infection, compared to the control cells (LentiV2) (Fig. 2h, i).

Proteomics analysis reveals the role of NEMO in inflammation related to H. pylori-CMTM3

CMTM3 affects many proteins at the post-transcriptional level [21]. Accordingly, we used proteomics technology to identify proteins affected by CMTM3, to explain why CMTM3 promoted IL-8 production and inhibited apoptosis of gastric epithelial cells during H. pylori infection. CMTM3 KO GES-1 cells were co-cultured with H. pylori (MOI 100:1) for 24 h and evaluated by whole protein label-free proteomics technology. We identified 2187 differentially expressed proteins between CMTM3 KO and LentiV2 GES-1 cells, including 122 up-regulated proteins and 151 down-regulated proteins (fold change > 2; Fig. 3a). Differentially expressed proteins were analyzed using the Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis. Four differentially expressed proteins, NEMO and three subunits of V-type proton ATPase, were involved in epithelial cell signaling in H. pylori infection (Fig. 3b). The heat map showed the Z-score of these proteins (Fig. 3c).

Fig. 3
figure 3

Proteomics analysis indicates that NEMO is involved in H. pylori-CMTM3-inflammation. a Differentially expressed proteins (P.adj < 0.05). b Kyoto Encyclopedia of Genes and Genomes. enrichment analysis. The TOP regulated signaling pathways were shown of CMTM3 KO vs control (LentiV2) in GES-1 cells (padj < 0.05). c Heat map of the expression levels of the differentially expressed proteins enriched in epithelial cell signaling in H. pylori infection signaling pathway. Red indicates high and blue indicates low protein expression. d NEMO expression was detected in CMTM3 KO GES-1 and HEK 293 T cells by western blotting. β-Actin was used as a control. Data are representative of three independent experiments. e NEMO expression was detected in CMTM3 KO GES-1 cells by qRT-PCR. Data is representative of three independent experiments. f Representative immunohistochemistry images of NEMO by human gastric tissues from the same patient before and after H. pylori infection (n = 11). g Summary of immunohistochemistry results for NEMO. Graph showing the average quantification of NEMO positive cells in at least 6 random fields of one patient. Data is expressed as means ± SEM. *p < 0.05. ns, no statistical difference

Full size image

The expression of NEMO, a key molecule in the NF-κB pathway, was decreased following CMTM3 knockout. We confirmed these results via western blotting, revealing that NEMO expression was down-regulated in CMTM3 knockout cells compared to the control cells (LentiV2) (Fig. 3d). However, CMTM3 had no obvious effects on NEMO expression at the mRNA level (Fig. 3e). These results suggested that CMTM3 might contribute to NEMO protein synthesis and degradation.

Using paired gastric tissues from the same patient before and after H. pylori infection, we evaluated the protein expression of NEMO by immunohistochemistry. The NEMO protein expression levels during H. pylori infection were significantly higher than those of H. pylori uninfected patients (Fig. 3f, g).

CMTM3 promotes IL-8 production and inhibits apoptosis of gastric epithelial cells during H. pylori infection by NEMO

To explore that CMTM3 promotes IL-8 production and inhibits apoptosis of gastric epithelial cells were dependent on NEMO, we overexpressed NEMO in CMTM3 KO cells. The IL-8 level was higher in pCMV-NEMO CMTM3 KO cells than the control (pCMV) CMTM3 KO cells on the mRNA (Fig. 4a) and protein level (Fig. 4b). These results suggested CMTM3 promoted IL-8 production during H. pylori infection by NEMO.

Fig. 4
figure 4

CMTM3 promotes IL-8 production and inhibits the apoptosis of gastric epithelial cells by NEMO. a, b The expression level of IL-8 was analyzed by qRT-PCR (a) and ELISA (b). After overexpression of NEMO (pCMV-NEMO) in CMTM3 KO GES-1 cells for 24 h, cells were treated with H. pylori for 24 h. pCMV was the control vector. Data is representative of three independent experiments. c, d Representative Annexin V/propidium iodide staining results (c). After overexpression of NEMO (pCMV-NEMO) in CMTM3 KO GES-1 cells for 24 h, cells were treated with H. pylori for 24 h. pCMV was the control vector. Annexin V-positive cells were analyzed (d). Data is representative of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001

Full size image

We overexpressed NEMO in CMTM3 KO cells. The proportion of apoptotic cells decreased in pCMV-NEMO CMTM3 KO cells than control (pCMV) CMTM3 KO cells (Fig. 4c, d). These results suggested CMTM3 inhibited apoptosis of gastric epithelial cells during H. pylori infection by NEMO.

CMTM3 reduces NEMO degradation

To further explore the detailed molecular mechanism between CMTM3 and NEMO, we expressed Flag-tagged NEMO in GES-1 cells and conducted a Flag pulldown assay. We found that CMTM3 interacted with NEMO (Fig. 5a). Additionally, we confirmed co-localization of CMTM3 and NEMO. As shown in Fig. 5b, co-localization of CMTM3 and NEMO occurred in the nucleus.

Fig. 5
figure 5

CMTM3 reduces NEMO degradation. a The immunoprecipitation analysis of GES-1 cells. Cells expressing pCMV-NEMO-3Flag were immunoprecipitated by an anti-Flag antibody and immunoblotted by anti-NEMO and anti-CMTM3 antibodies. b Co-localization of CMTM3 and NEMO in GES-1 cells was investigated by immunofluorescence co-localization analysis after H. pylori infection for 24 h. Scale bar, 10 μm. Hochest was used for nuclear staining. c, d CMTM3 knockout GES-1 cells were treated with cycloheximide (25 µg/mL) and proteins were subjected to immunoblotting (c). Data is representative of three independent experiments. The remaining NEMO was quantified (d). e The ubiquitylation of NEMO. HEK 293 T cells were transfected with the indicated vectors. After 48 h transfection, cells were treated with MG132 (10 μM) for 6 h. Then cells were lysed and immunoprecipitated with anti-Flag antibody and analyzed by immunoblotting with the indicated antibodies. f CMTM3 KO GES-1 cells were treated with MG132 (10 μM) and collected at indicated time points. Whole-cell lysates were subjected to immunoblotting with indicated antibodies. g The expression the phosphorylated IKBα (p-IKBα) and phosphorylated p65 (p-p65) were analyzed in CMTM3 KO GES-1 cells.*p < 0.05

Full size image

Thus, we assessed the functions of CMTM3 on NEMO degradation using cycloheximide, which could bind to the 80S ribosomes to inhibit protein biosynthesis in eukaryotes. As shown in Fig. 5c, d, NEMO degradation was accelerating in CMTM3 KO cells compared with control (LentiV2) cells. Altogether, CMTM3 upregulated NEMO expression by inhibiting NEMO degradation in GES-1 cells.

ubiquitylation, a kind of protein modification, is crucial for NEMO degradation. We discovered that CMTM3 inhibited total ubiquitylation level of NEMO (Fig. 5e). Next, we treated GES-1 cells with proteasomal inhibitor MG132 to investigate the possibility that NEMO is regulated by CMTM3. Expression of NEMO was recovered in the presence of MG132 (Fig. 5f), suggesting that CMTM3 regulated the proteasomal degradation of NEMO.

As CMTM3 reduced NEMO degradation, we detected the effect of CMTM3 KO in IKBα and p65 phosphorylation which reflected the NF-κB pathway activity. Upon H. pylori treatment, IKBα and p65 phosphorylation decreased iKO cells compared with control (LentiV2) cells (Fig. 5g). Therefore, these data suggest that CMTM3 may promote the NEMO/NF-kB pathway.

Discussion

H.pylori is related to peptic ulcer disease and gastric cancer [27,28,29]. Although most people develop asymptomatic infections, the eradication of H. pylori reduces the risk of gastric cancer in asymptomatic individuals [30]. But the eradication rate under triple antibiotic therapy is less than 80% in most countries [3]. Therefore, treating H. pylori infection is problematic.

Many studies have demonstrated that CMTM3 contributes to cancers and acts as a gastric cancer suppressor [20, 21]. However, the role of CMTM3 during H. pylori infection, representing an early stage in the development of gastric cancer, is unclear. Here, we revealed that CMTM3 increased in the acute H. pylori infection and promoted IL-8 expression, suggesting that CMTM3 may play an important role in the inflammatory response to the H. pylori. More and more members of the CMTM family have been reported to participate in the immune response. CMTM6 and CMTM4 reduce the ubiquitylation of PD-L1 and increase its protein half-life, which affects tumor immune responses [22, 23]. CMTM4 is also identified as a component of IL-17R and mediates autoimmune diseases [24]. This work characterizes a new role of CMTM3 as an immunity regulator during H. pylori infection.

A whole genome analysis of the gastric epithelial cells response to H. pylori exposure reveals that IL-8 is the most markedly up-regulated gene [31]. IL-8 recruits neutrophils and lymphocytes to the infected gastric tissue to eliminate H. pylori in the early stage of infection. IL-8 is also involved in Th17 cell differentiation [32, 33]. Th17 is involved in protection against H. pylori via IL-17 secretion, which is important for eliminating H. pylori [34]. However, extremes are dangerous. The milieu of excessive chronic inflammatory reaction increases the risk of neoplastic changes. It is reported that IL-8 is up-regulated in many cancers and has tumourigenic effects by long-term stimulating angiogenesis, neutrophil recruitment and proliferation and migration of tumour cells [35,36,37]. However, it takes a long time for from inflammation to tumor. GES-1 cells are co-cultured with H. pylori for 45 days and present with the characteristics of intestinal-type gastric cancers in vitro [38]. In another study, treating cells with H. pylori repeatedly every 24 h for approximately 8 weeks is considered as a chronic infection model [39]. In our study, the cell-H. pylori coculture for 24 h may only represent the conditon of an acute inflammatory. Moreover, we should notice that only a few H. pylori-infected individuals will develop a chronic inflammatory response, suggesting that there are precise regulatory mechanisms for the inflammation. Next, We plan to generate CMTM3 KO mouse models to study the long-term role of CMTM3 in the development of H. pylori-related diseases.

H. pylori strongly adheres to gastric cells and causes diverse cell damage via its major cytotoxins, and proteins. We have previously shown that H. pylori considerably induces apoptosis in gastric epithelial cells at the early stage of infection [26]. H. pylori induces the apoptosis of gastric epithelial cells to reduce the production of gastric acid secretion in the stomach, which is benefit for its gastric colonization [40]. Elevated apoptosis correlates with increased disintegration of cell monolayers, which destroys the local homeostasis [41]. According to the report, IL-33 can promote the restoration of gastric cell homeostasis, due to the inhibition apoptosis [42, 43]. Besides, gastric epithelial cells are part of gastric mucosal barrier, which integrity is crucial for the prevention of H. pylori- related gastric diseases [44]. In this study, we discovered that CMTM3 inhibits the H. pylori-induced apoptosis of gastric epithelial cells, which may affect the integrity of the gastric mucosal epithelial barrier and H. pylori colonization.

NEMO, a crucial scaffolding molecule in the activation of NF-κB, was identified in the proteomics analysis (LentiV2 vs. CMTM3 KO GES-1 cells) [45]. The NF-κB pathway induces the expression of cytokines and anti-apoptosis proteins in gastric epithelial cells, which is critical for the immune response and cell survival [46]. In hepatocytes, NEMO physiologically inhibits apoptosis by regulating NF-κB activation and also preventing the formation of the complex RIPK1- FADD- Caspase-8 [47, 48]. TRIM14 induces IL-8 expression by directly binding to NEMO and promotes the phosphorylation of IKBα and p65 [49]. Many pathogens, such as SARS-CoV-2, Brucella melitensis, and Shigella, disrupt NF-κB signaling and immune responses by targeting NEMO during infection, resulting in persistent infection [50,51,52]. In this study, we discovered that CMTM3 inhibited the H. pylori-induced apoptosis and promoted the IL-8 expression in gastric epithelial cells. CMTM3 interacts directly with NEMO in the nucleus under H. pylori treatment. It has been reported that NEMO can be ubiquitinated in the nucleus under genotoxic stress, which is a key step in the activation of NF-κB [53]. DNA damage activates IKK-unbound NEMO in the nucleus via SUMO (small ubiquitin-like modifier) -1 attachment and ATM-dependent ubiquitylation. Then NEMO shifts from the nucleus to the cytoplasm to activate IKK [54]. TRIM37, a novel E3 ligase, plays a vital role in the nuclear export of NEMO and IKK/NF-κB activation via ubiquitylation of NEMO in the nucleus [55]. Therefore, we speculated that CMTM3 regulated the ubiquitylation of NEMO in the nucleus, thereby affecting NEMO degradation and NF-κB activation [56]. While we characterized the CMTM3 inhibited total ubiquitylation level of NEMO, further research is needed to identify the type of NEMO ubiquitylation regulated by CMTM3 and its underlying mechanism.

Long-term asymptomatic H. pylori infection is associated with an increased risk for the development of H. pylori-related diseases. CMTM3 is up-regulated during H. pylori infection, which promotes IL-8 production and inhibits the apoptosis of gastric epithelial cells. Accordingly, the appropriate expression of CMTM3 may play a vital role in the immunity for the eradication of H. pylori.

Conclusion

CMTM3 reduces apoptosis and promotes IL-8 expression in the gastric epithelial cells by stabilizing NEMO during H. pylori infection. These findings characterize a new role for CMTM3 in host–pathogen interactions and provide novel insight into the molecular regulation of NEMO (Fig. 6).

Fig. 6
figure 6

Schematic diagram of CMTM3 function during H. pylori infection. H. pylori induces CMTM3 expression, and CMTM3 promotes IL-8 production and inhibits the apoptosis of gastric epithelial cells by stabilizing NEMO

Full size image

Methods

Tissues and immunohistochemistry

Human gastric mucosal tissues were collected from the Department of Digestive Pathology of the Peking University Third Hospital (Beijing, China). Eleven paired samples of the gastric mucosa were obtained from the same patient who was infected with H. pylori and successfully eradicated H. pylori for more than one year. Because H. pylori can adsorb anions and appear black, Warthin-Starry staining was used to confirm H. pylori infection. If there is H. pylori infection, there are helix rods in the gastric mucosa under Warthin-Starry staining [57]. CMTM3 and NEMO immunohistochemistry were performed as previously described, following the instructions of the antibodies [58]. Six fields were randomly selected for analysing by ImageJ 1.52a software (Silver Spring, Maryland, USA). Average number of the positive area was compared by paired t-tests. The Ethics Committee of the Peking University Third Hospital approved the study (decision numbers S2022179).

Antibodies

Detailed information regarding the antibodies used in this study is provided in Table 1.

Table 1 Detailed information about antibodies
Full size table

Animals

Six- to eight-week-old male C57BL/6 mice were obtained from the Laboratory Animal Science of Peking University (Beijing, China). The mice were divided into 2 groups, the control (NC) and H. pylori-infection (PMSS1) group. H. pylori strain PMSS1 was utilized in this study [39]. Briefly, after fasting for 24 h, mice in PMSS1 and NC groups were intragastrically administered 2.5 × 109 CFU PMSS1 and isometric Brucella broth respectively every other day for 3 times. After 8 weeks of infection, the mice were sacrificed [40]. The Ethics Committee of the Peking University Third Hospital authorized the animal research (decision numbers SA2022156).

H. pylori strains

H. pylori strain PMSS1 was a kind gift from the Chinese Center for Disease Control and Prevention. H. pylori 26695 was maintained in our laboratory. H. pylori strain was verified by H. pylori urease test kit (Begen, Sanming, China), Gram staining, and sequencing results. H. pylori urease test kit is based on that H. pylori secretes a large amount of highly active urease which can catalyze urea and produce ammonia. The pH value increases and causes the indicator to change into red. H. pylori infection can be determined according to the color change [59]. Besides, H. pylori is a gram-negative bacillus which is a blue curved rod under the gram staining. H. pylori was cultured following standard protocol [58]. Briefly, H. pylori was cultured on Karmali solid medium containing 10% sterile defibrinated sheep blood. Every two days, the H. pylori was passaged. H. pylori was cultured under micro-aerobic conditions (10% CO2, 85% N2, 5% O2, and 37 °C).

Gastric epithelial single cell suspension and flow cytometry

Briefly, the stomachs of the mice in each group were removed and washed with PBS. The glandular stomachs were cut and incubated in 5 mM EDTA for 2 h at 4 °C with gentle shaking. Then, isolated glands were passed through a 70 µm nylon mesh cell strainer, and centrifuged at 150 × g for 5 min [60]. Surface antigen stainings were performed using antibodies against CMTM3 (kindly provided by Prof. Han Wenling) and Fixable Viability Dye eFluor on ice for 30 min. The percentage of CMTM3 positive cells was analyzed using a BD flow cytometer (Franklin Lake, New Jersey, USA) and results were analyzed by FlowJo 10.8.1 (Franklin Lake, New Jersey, USA).

Cell culture and infection

Human cell lines HEK 293 T, and AGS were maintained from ATCC (Manassas, Virginia, USA). Human cell line GES-1 was from Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China). GES-1 and AGS cells were cultured in Roswell Park Memorial Institute 1640 medium (HyClone, Logan, Utah, USA) containing 10% fetal bovine serum (Gibco, Waltham, Massachusetts, USA), and 100 U/mL penicillin–streptomycin (Gibco). HEK 293 T cells were cultured in DMEM (HyClone) supplemented with 10% fetal bovine serum and 100 U/mL penicillin–streptomycin. Cells were cultured at 37 °C with 5% CO2.

The H. pylori-cell co-culture experiment was carried out as described previously [61]. Briefly, cells were seeded in proper cell culture plates or dishes. After 12 h, H. pylori was collected from the solid medium, washed, and resuspended in PBS. The quantity of H. pylori was measured at 530 nm absorbance using a spectrophotometer. The H. pylori was added to the culture medium of cells at the multiplicity of infection (MOI) 100:1 at 37 °C with 5% CO2, without penicillin–streptomycin.

Western blotting

Cells were washed with cold PBS and then lysed by RIPA buffer (Solarbio, Beijing, China) with protease and phosphatase inhibitors (Solarbio) on ice for 30 min. The protein concentration was estimated using the BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, Massachusetts, USA). For SDS-PAGE and immunoblotting, samples were heated at 99 °C for 10 min, separated on Tris–Glycine gels at the constant condition of 30 mA, and transferred onto membranes (Millipore, Billerica, Massachusetts, USA) at the constant condition of 100 V for 2 h. After blocking with 5% nonfat milk or 5% bovine serum albumin for 1 h at room temperature (RT), the membranes were incubated with the first antibodies for 16 h at 4 ℃ and the second antibodies for 1 h at RT. Enhanced chemiluminescence reagent (Yamei, Shanghai, China) or the Odyssey detection system (LI-COR, Lincoln, Nebraska, USA) were used to detect protein expression. Gray values obtained by western blotting were analyzed by ImageJ 1.52a software.

Generation of CMTM3 knockout cells

For the generation of CMTM3 knockout (CMTM3 KO) cells, HEK 293 T or GES-1 cells were infected with a lentivirus (lentiCRISPR v2) encoding a guide RNA (gRNA) (5′-CCTGCCGGCGGCTCCCGTCCCGG-3′). The gRNA was designed via Zhang Lab (https://zlab.bio/guide-design-resources). The lentiviruses were produced by HEK 293 T cells with three vectors, lentiCRISPRv2-gRNA, pCMV-VSV-G, and psPAX2. Cells were infected with the lentivirus containing lentiCRISPRv2-gRNA. The CMTM3 stable knockout cells were screened out by puromycin (Yuanye, Shanghai, China).

Plasmids and cell transfection

The plasmid pCMV-MCS-IKBKG-3FLAG (pCMV-NEMO-3FLAG) was bought from Yibaike, (Beijing, China). pCMV-CMTM3 was a kind gift from Prof. Wenling Han. Cells were transfected with plasmids using Lipofectamine 2000 transfection reagent (Invitrogen, Shanghai, China) and Opti-MEM (Gibco). After the transfection for 24 h, cells were applied to H. pylori-cell co-culture.

siRNA transfection

To knock down endogenous NEMO, small interfering RNA (siRNA) constructs were purchased from RIBOBIO (Guangzhou, China; genOFFTM st-h-IKBKG_001:5′-AGTTGCAGGTGGCCTATCA-3′). AGS cells were transfected with siRNA at a final concentration of 50 nM, using RFect siRNA Transfection Reagent (Baidai, Changzhou, China). After the transfection for 48 h, cells were applied to H. pylori-cell co-culture.

qRT-PCR

The total RNA was extracted by TRIzol (Invitrogen). Reverse transcription and qRT-PCR were performed using the Fast-King RT Kit and qPCR Mix SYBR Green Kit (Tiangen Biotech, Beijing, China). Amplifications were performed according to the manufacturer’s instructions. Sequences of quantitative qRT-PCR primers are mentioned in Table 2. β-ACTIN was used as a control. Relative mRNA expression levels of IL-8 and H. pylori 16S rRNA were determined using the 2−∆∆Ct method.

Table 2 Sequences of qRT-PCR primers
Full size table

Apoptosis assay

GES-1 cells were seeded in 12-well plates at a density of 2 × 105. After co-culture with H. pylori (MOI 100:1) for 24 h, the culture medium and cells were collected and washed with PBS. An Annexin V/propidium iodide Apoptosis Detection Kit (Dojindo, Shanghai, China) was used according to the instruction of the manufacturer. The samples were analyzed by flow cytometry (Beckman, Bria, California, USA). A blank and positive control were made. Apoptosis was induced as a positive control at 55 ℃ for 2 min.

Proteome and data analysis

CMTM3 KO GES-1 cells were seeded at a density of 4 × 106 cells per 10 cm dish. After 12 h, GES-1 cells were co-cultured with H. pylori (MOI 100:1) for 24 h. Cells were washed with PBS, collected, and preserved at − 80 °C for the label-free proteome analysis by Novogene Co. Ltd. (Beijing, China).

Proteins were quantified by Bradford protein quantitative kit. 20 μg protein sample was loaded to 12% SDS-PAGE gel. The concentrated gel was carried out at 80 V for 20 min, the separation gel at 120 V for 90 min. Then, the gel was stained by Coomassie Brilliant Blue R-250 and decolored. Protein samples were treated with DB lysis buffer, trypsin, and TEAB buffer at 37 °C for 4 h. Then trypsin and CaCl2 were added to digest the proteins overnight. Formic acid was added to the digested samples and centrifuged at 12,000 × g for 5 min, at RT. The supernatant was slowly loaded to the C18 desalting column and washed 3 times with washing buffer, then added to an elution buffer. The eluents of each sample were collected and lyophilized. The powder was dissolved in 10 μL of solution A (100% water, 0.1% formic acid), and centrifuged at 14,000 × g for 20 min at 4 ℃. 1 µg peptide were separated and analyzed by Q ExactiveTM HF-X mass spectrometer (Thermo Fisher Scientific). All spectra were searched against the homo_sapiens_uniprot_2021_7_15.fasta (202,195 sequences) database, using Proteome Discoverer 2.2 (PD 2.2; Thermo).

Differentially expressed proteins, with an adjusted p-value (padj) < 0.05 and a fold change > 2, were considered as differentially expressed, as shown by the volcano map. The Cluster Profiler R package was used to test the statistical enrichment of differentially expressed proteins in the Kyoto Encyclopedia of Genes and Genomes database. The difference was considered significant at padj < 0.05. Proteins of interest were analyzed by Z-score and presented in a heat map.

Immunoprecipitation

GES-1 cells, transfected with pCMV-MCS-IKBKG-3FLAG for 48 h, were used for immunoprecipitation. The cells were collected and lysed by immunoprecipitation RIPA buffer (Solarbio) with protease and phosphatase inhibitors, on ice for 30 min. The whole cell lysate (2 mg) was used for immunoprecipitation with 8 µg anti-flag or mouse IgG isotype control antibody for 16 h at 4 °C with rotation. Then, 50 µL of pre-cleared Protein G Sepharose beads (Thermo Fisher Scientific) were added to the antibody-antigen complex and incubated for another 4 h at 4 °C. The bead-antibody-antigen compound was washed 5 times and analyzed by western blotting.

NEMO degradation assay

GES-1 KO cells were treated with 25 μg/mL cycloheximide (Selleck, Shanghai, China). At the 0, 4, 8, 12 h, cells were washed with PBS and collected. The remaining NEMO was measured by western blotting, as described above.

Immunofluorescence

GES-1 cells were seeded on a glass culture dish. The cells were fixed with paraformaldehyde for 15 min. After the cells were permeabilized by 1% TritonX-100 for 15 min at RT, cells were blocked with 5% bovine serum albumin for 1 h at RT. Cells were then incubated with the primary antibodies at 4 °C for 16 h, washed, and incubated with the secondary antibodies for 1 h at RT. Cells were stained with Hoechst 33,342 (Beyotime, Beijing, China) for 10 min at RT. Images were acquired by a Zeiss confocal microscope (Oberkochen, Badenwueberg, Germany).

Luciferase reporter assay

GES-1 cells were seeded in 12-well plates at a density of 2 × 105 cells for 16 h. GES-1 cells were transfected with 1 µg pGL3-Basic-CMTM3-promotor vector or 1 µg pGL3-Basic vector and 1 µg thymidine kinase promoter-Renilla (TK-Renilla)luciferase reporter vector, using 4 µl Lipofectamine2000. pGL3-Basic-CMTM3-promotor vector and TK-Renilla vector were bought from Sangon (Shanghai, China). After 24 h transfection, cells were treated with H. pylori (MOI 100:1) for 24 h. Luciferase activity was then determined, using a dual-luciferase reporter assay system (Meilunbio, Dalian, China) following the instruction of the manufacturer. Renilla vector was measured as a control. The relative luciferase activity was calculated as Firefly/Renilla ratio.

HA-ubiquitin pull-down assay

HEK 293 T cells were seeded in 10 cm dishes at a density of 4 × 106 for 16 h and transfected with 4 µg pCMV-NEMO-3FLAG, 4 µg Ha-Ub (Yibaike, Beijing, China), and 4 µg pCMV-CMTM3, or 4 µg pCMV vector, using 24 µl Lipofectamine2000. After 48 h transfection, cells were treated with 10 μM MG132 (Selleck) for 6 h. Thereafter, the cells were washed with cold PBS, collected, and lysed by immunoprecipitation RIPA buffer (Solarbio) with protease and phosphatase inhibitors (Solarbio) and N-ethyl malebutylene diimide (Meilun, Dalian, China), on ice for 30 min. 2 mg of whole cell lysate was used for immunoprecipitation with 8 µg anti-Flag antibody or mouse IgG isotype control antibody overnight at 4 °C with rotation. Then, 50 µL pre-cleared Protein G Sepharose beads (Thermo) were added to the antibody-antigen complex and incubated for another 4 h at 4 °C. The bead-antibody-antigen compound was washed 5 times with immunoprecipitation RIPA buffer, containing protease and phosphatase inhibitors and N-ethyl malebutylene diimide buffer. The samples were loaded onto a 7.5% SDS-PAGE gel and analyzed by western blotting.

Statistical analysis

Statistical analyses were performed using SPSS software 27.0 (Chicago, Ilinois, USA). Student's t-test or ANOVA was used to evaluate significant differences. p < 0.05 was considered statistically significant.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

References

  1. Hooi J, Lai WY, Ng WK, Suen M, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.

    Article  PubMed  Google Scholar 

  2. Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther. 2017;46(9):773–9.

    Article  CAS  PubMed  Google Scholar 

  3. Zhang M. High antibiotic resistance rate: a difficult issue for Helicobacter pylori eradication treatment. World J Gastroenterol. 2015;21(48):13432–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Niv Y. H. pylori recurrence after successful eradication. World J Gastroenterol. 2008;14(10):1477–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Morey P, Pfannkuch L, Pang E, Boccellato F, Sigal M, Imai-Matsushima A, et al. Helicobacter pylori depletes cholesterol in gastric glands to prevent interferon gamma signaling and escape the inflammatory response. Gastroenterology. 2017;154(5):1391–404.

    Article  PubMed  Google Scholar 

  6. Ashktorab H, Dashwood RH, Dashwood MM, Zaidi SI, Hewitt SM, Green WR, et al. H. pylori-induced apoptosis in human gastric cancer cells mediated via the release of apoptosis-inducing factor from mitochondria. Helicobacter. 2008;13(6):506–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bellet MM, Pieroni S, Castelli M, Piobbico D, Fallarino F, Romani L, et al. HOPS/Tmub1 involvement in the NF-kB-mediated inflammatory response through the modulation of TRAF6. Cell Death Dis. 2020;11(10):865.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wan XK, Yuan SL, Tao HX, Diao LP, Wang YC, Cao C, et al. The upregulation of TRAF1 induced by Helicobacter pylori plays an antiapoptotic effect on the infected cells. Helicobacter. 2016;21(6):554–64.

    Article  CAS  PubMed  Google Scholar 

  9. Ferrand J, Lehours P, Schmid-Alliana A, Megraud F, Varon C. Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-kappaB-dependent pathway. PLoS ONE. 2011;6(12): e29007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Maubach G, Schm Dicke AC, Naumann M. NEMO links nuclear factor-κB to human diseases. Trends Mol Med. 2017;23(2):1138–55.

    Article  CAS  PubMed  Google Scholar 

  11. May MJ, D’Acquisto F, Madge LA, Gloeckner J, Pober JS, Ghosh S. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science. 2000;289(5484):1550–4.

    Article  CAS  PubMed  Google Scholar 

  12. Sun S, Ganchi P, Ballard D, Greene W. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science. 1993;259(5103):1912–5.

    Article  CAS  PubMed  Google Scholar 

  13. Xz A, Lz A, Ll A, Zz A, Bo ZA, Jy A, et al. MxA suppresses TAK1-IKKα/β-NF-κB mediated inflammatory cytokine production to facilitate Mycobacterium tuberculosis infection. J Infect. 2020;81(2):231–41.

    Article  Google Scholar 

  14. Zhuo Y, Guo Z, Ba T, Zhang C, He L, Zeng C, et al. African swine fever virus MGF360-12L inhibits type I interferon production by blocking the interaction of importin alpha and NF-kappaB signaling pathway. Virol Sin. 2021;36(2):176–86.

    Article  CAS  PubMed  Google Scholar 

  15. Han W, Ding P, Xu M, Wang L, Rui M, Shi S, et al. Identification of eight genes encoding chemokine-like factor superfamily members 1–8 (CKLFSF1-8) by in silico cloning and experimental validation. Genomics. 2003;81(6):609–17.

    Article  CAS  PubMed  Google Scholar 

  16. Han W, Lou Y, Tang J, Zhang Y, Chen Y, Li Y, et al. Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem J. 2001;357(Pt 1):127–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Su Y, Lin Y, Zhang L, Liu B, Yuan W, Mo X, et al. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer. Cancer Sci. 2014;105(1):26–34.

    Article  CAS  PubMed  Google Scholar 

  18. Yuan W, Liu B, Wang X, Li T, Xue H, Mo X, et al. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer. Cancer Lett. 2017;386:77–86.

    Article  CAS  PubMed  Google Scholar 

  19. Chrifi I, Louzao-Martinez L, Brandt M, Dijk CV, Burgisser P, Zhu C, et al. CMTM3 (CKLF-like marvel transmembrane domain 3) mediates angiogenesis by regulating cell surface availability of VE-cadherin in endothelial adherens junctions. Arterioscler Thromb Vasc Biol. 2017;37(6):1098–114.

    Article  CAS  PubMed  Google Scholar 

  20. Li AY, Wu YX, Gao N, Zhang JG, Meng W. Expression and biological function of CMTM3 in gastric cancer. World Chin J Digestol. 2021;29(3):116–24.

    Article  Google Scholar 

  21. Yuan W, Liu B, Wang X, Li T, Han W. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer. Cancer Lett. 2017;386:77–86.

    Article  CAS  PubMed  Google Scholar 

  22. Burr ML, Sparbier CE, Chan YC, Williamson JC, Woods K, Beavis PA, et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 2017;549(7670):101–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Mezzadra R, Sun C, Jae LT, Gomez-Eerland R, de Vries E, Wu W, et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature. 2017;549(7670):106–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Knizkova D, Pribikova M, Draberova H, Semberova T, Trivic T, Synackova A, et al. CMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology. Nat Immunol. 2022;23(11):1644–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Choi MS, Ze EY, Park JY, Shin TS, Kim JG. Helicobacter pylori-derived outer membrane vesicles stimulate interleukin 8 secretion through nuclear factor kappa B activation. Korean J Intern Med. 2021;36(4):854–67.

    Article  PubMed  Google Scholar 

  26. Yanyan S, Yanlei G, Ting Z, Shigang D. Hydrotalcite can prevent the damaging effects of Helicobacter pylori on gastric epithelial cells. Microsc Microanal. 2018;24(3):277–83.

    Article  PubMed  Google Scholar 

  27. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136(6):1863–73.

    Article  CAS  PubMed  Google Scholar 

  28. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735–40.

    CAS  PubMed  Google Scholar 

  29. Peek RJ, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2(1):28–37.

    Article  CAS  PubMed  Google Scholar 

  30. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321(23):1562–6.

    Article  CAS  PubMed  Google Scholar 

  31. Eftang LL, Esbensen Y, Tannaes TM, Bukholm IR, Bukholm G. Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol. 2012;12:9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, et al. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol. 2000;165(9):5332–7.

    Article  CAS  PubMed  Google Scholar 

  33. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, Ramsay N, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol. 1994;47(1):61–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Delyria ES, Redline RW, Blanchard TG. Vaccination of mice against H. pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology. 2009;136(1):247–56.

    Article  CAS  PubMed  Google Scholar 

  35. Purcell RV, Permain J, Keenan JI. Enterotoxigenic Bacteroides fragilis activates IL-8 expression through Stat3 in colorectal cancer cells. Gut Pathog. 2022;14(1):16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hirooka Y, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2487–93.

    Article  CAS  PubMed  Google Scholar 

  37. Bockerstett KA, DiPaolo RJ. Regulation of gastric carcinogenesis by inflammatory cytokines. Cell Mol Gastroenterol Hepatol. 2017;4(1):47–53.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Yu XW, Xu Y, Gong YH, Qian X, Yuan Y. Helicobacter pylori induces malignant transformation of gastric epithelial cells in vitro. APMIS. 2011;119(3):187–97.

    Article  PubMed  Google Scholar 

  39. Liu JF, Guo D, Kang EM, Wang YS, Gao XZ, Cong HY, et al. Acute and chronic infection of H. pylori caused the difference in apoptosis of gastric epithelial cells. Microb Pathog. 2021;150:104717.

    Article  CAS  PubMed  Google Scholar 

  40. Boquet P, Ricci V, Galmiche A, Gauthier NC. Gastric cell apoptosis and H. pylori: has the main function of VacA finally been identified? Trends Microbiol. 2003;11(9):410–3.

    Article  CAS  PubMed  Google Scholar 

  41. Gonciarz W, Krupa A, Hinc K, Obuchowski M, Moran AP, Gajewski A, et al. The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts. PLoS ONE. 2019;14(8):e220636.

    Article  Google Scholar 

  42. Gonciarz W, Krupa A, Moran AP, Tomaszewska A, Chmiela M. Interference of LPS H. pylori with IL-33-driven regeneration of caviae porcellus primary gastric epithelial cells and fibroblasts. Cells. 2021;10(6):1385.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Mnich E, Kowalewicz-Kulbat M, Sicinska P, Hinc K, Obuchowski M, Gajewski A, et al. Impact of Helicobacter pylori on the healing process of the gastric barrier. World J Gastroenterol. 2016;22(33):7536–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Wu J, Xu S, Zhu Y. Helicobacter pylori CagA: a critical destroyer of the gastric epithelial barrier. Dig Dis Sci. 2013;58(7):1830–7.

    Article  CAS  PubMed  Google Scholar 

  45. Fujita H, Rahighi S, Akita M, Kato R, Sasaki Y, Wakatsuki S, et al. Mechanism underlying IκB kinase activation mediated by the linear ubiquitin chain assembly complex. Mol Cell Biol. 2019;34(7):1322–35.

    Article  Google Scholar 

  46. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5(11):1166–74.

    Article  CAS  PubMed  Google Scholar 

  47. Hsin IF, Montano E, Seki E. Finding a new role for NEMO: a key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1. Hepatology. 2016;64(1):295–7.

    Article  PubMed  Google Scholar 

  48. Kondylis V, Polykratis A, Ehlken H, Ochoa-Callejero L, Straub BK, Krishna-Subramanian S, et al. NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis. Cancer Cell. 2015;28(5):582–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Huang X, Li Y, Li X, Fan D, Xin HB, Fu M. TRIM14 promotes endothelial activation via activating NF-kappaB signaling pathway. J Mol Cell Biol. 2020;12(3):176–89.

    Article  CAS  PubMed  Google Scholar 

  50. Wu J, Shi Y, Pan X, Wu S, Hou R, Zhang Y, et al. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. 2021;34(7): 108761.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Zhou Y, Bu Z, Qian J, Cheng Y, Qiao L, Yang S, et al. Brucella melitensis UGPase inhibits the activation of NF-kappaB by modulating the ubiquitination of NEMO. BMC Vet Res. 2021;17(1):289.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Ashida H, Kim M, Schmidt-Supprian M, Ma A, Ogawa M, Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat Cell Biol. 2010;12(1):66–73, 1–09.

  53. Medunjanin S, Putzier M, Nothen T, Weinert S, Kahne T, Luani B, et al. DNA-PK: gatekeeper for IKKgamma/NEMO nucleocytoplasmic shuttling in genotoxic stress-induced NF-kappaB activation. Cell Mol Life Sci. 2020;77(20):4133–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell. 2003;115(5):565–76.

    Article  CAS  PubMed  Google Scholar 

  55. Wu G, Song L, Zhu J, Hu Y, Cao L, Tan Z, et al. An ATM/TRIM37/NEMO axis counteracts genotoxicity by activating nuclear-to-cytoplasmic NF-kappaB signaling. Cancer Res. 2018;78(22):6399–412.

    Article  CAS  PubMed  Google Scholar 

  56. Gautheron J, Courtois G. “Without Ub I am nothing”: NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation. Cell Mol Life Sci. 2010;67(18):3101–13.

    Article  CAS  PubMed  Google Scholar 

  57. Kocak BT, Saribas S, Demiryas S, Yilmaz E, Uysal O, Kepil N, et al. Association between polymorphisms in HLA-A, HLA-B, HLA-DR, and DQ genes from gastric cancer and duodenal ulcer patients and cagL among cagA-positive Helicobacter pylori strains: the first study in a Turkish population. Infect Genet Evol. 2020;82: 104288.

    Article  CAS  PubMed  Google Scholar 

  58. Guo Y, Zhang T, Shi Y, Zhang J, Li M, Lu F, et al. Helicobacter pylori inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathway. Helicobacter. 2020;25(1): e12665.

    Article  CAS  PubMed  Google Scholar 

  59. Lopes AI, Vale FF, Oleastro M. Helicobacter pylori infection—recent developments in diagnosis. World J Gastroenterol. 2014;20(28):9299–313.

    PubMed  PubMed Central  Google Scholar 

  60. Soutto M, Chen Z, Bhat AA, Wang L, El-Rifai W. Activation of STAT3 signaling is mediated by TFF1 silencing in gastric neoplasia. Nat Commun. 2019;10(1):3039.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Shi Y, Wang P, Guo Y, et al. Helicobacter pylori-induced DNA damage is a potential driver for human gastric cancer AGS cells. DNA Cell Biol. 2019;38(3):272–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Prof. Han Wenling for providing guidance and antibodies. We thank Editage (www.editage.cn) for English language editing.

Funding

This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 82270592 and 11702004).

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, 100191, People’s Republic of China

    Jing Zhang, Jing Ning, Weiwei Fu, Jing Zhang & Shigang Ding

  2. Research Center of Clinical Epidemiology, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, 100191, People’s Republic of China

    Yanyan Shi

Authors
  1. Jing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing Ning
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weiwei Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yanyan Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shigang Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SD and JZ conceived the study. JZ (junior) and JN carried out the experiments, analyzed and interpreted the data and drafted the manuscript. YS and WF contributed to data analysis and edited the manuscript. All authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Shigang Ding.

Ethics declarations

Ethics approval and consent to participate

The Ethics Committee of the Peking University Third Hospital approved the study.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, J., Ning, J., Fu, W. et al. CMTM3 protects the gastric epithelial cells from apoptosis and promotes IL-8 by stabilizing NEMO during Helicobacter pylori infection. Gut Pathog 15, 6 (2023). https://doi.org/10.1186/s13099-023-00533-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13099-023-00533-4

Keywords

Gut Pathogens

ISSN: 1757-4749